Evidence map›Paper›PMID 38696672›Full record

Trial reportDiabetes technology & therapeutics2024

Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes.

Carol J Levy, Ryan Bailey, Lori M Laffel, Gregory Forlenza, Linda A DiMeglio, Michael S Hughes, Sue A Brown, Grazia Aleppo, Anuj Bhargava, Viral N Shah and 12 more

Registry-linked trialAbstract readMulticenter StudyClinical Trial
In one paragraph

Trial report in Diabetes technology & therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05403502 (Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05403502 nacompletednot on this map

Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes

TypeinterventionalSponsorTandem Diabetes Care, Inc.Ran2022 to 2023Enrolled183ConditionsType 1 DiabetesArmst:slim X2 insulin pump with Control-IQ technology 1.5
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. The Future of Automated Insulin Delivery Systems.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Artificial Pancreas: The First 20 Years.Journal of diabetes science and technology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Carol J LevyDivision of Endocrinology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.ORCID 0000-0002-3492-2578
Ryan BaileyJaeb Center for Health Research, Tampa, Florida, USA.ORCID 0000-0001-5763-4598
Lori M LaffelResearch Division, Joslin Diabetes Center and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-9675-3001
Gregory ForlenzaBarbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.ORCID 0000-0003-3607-9788
Linda A DiMeglioDepartment of Pediatrics, Division of Pediatric Endocrinology and Diabetology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Michael S HughesDepartment of Medicine, Division of Endocrinology, Gerontology and Metabolism, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000-0002-3729-0350
Sue A BrownDivision of Endocrinology, Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Grazia AleppoDivision of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Anuj BhargavaIowa Diabetes and Endocrinology Research Center, West Des Moines, Iowa, USA.
Viral N ShahBarbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Mark A ClementsDepartment of Pediatrics, Division of Endocrinology and Diabetes, Children's Mercy Kansas City, Kansas City, Missouri, USA.
Mark KipnesDiabetes & Glandular Disease Clinic, San Antonio, Texas, USA.
Brittany BruggemanDepartment of Pediatrics, Division of Endocrinology, University of Florida, Gainesville, Florida, USA.ORCID 0000-0002-5117-8031
Mark DanielsDivision of Endocrinology and Diabetes, Children's Hospital of Orange County, Orange, California, USA.
Henry RodriguezUSF Diabetes and Endocrinology Center, University of South Florida, Tampa, Florida, USA.
Peter CalhounJaeb Center for Health Research, Tampa, Florida, USA.ORCID 0000-0002-5325-7200
John W LumJaeb Center for Health Research, Tampa, Florida, USA.
Ravid Sasson-KatchalskiTandem Diabetes Care, San Diego, California, USA.
Jordan E PinskerTandem Diabetes Care, San Diego, California, USA.ORCID 0009-0004-7621-5267
Robyn PollomEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.
Roy W BeckJaeb Center for Health Research, Tampa, Florida, USA.ORCID 0000-0002-5194-8446
TL1 Study Group

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
NIDDK NIH HHS P30 DK036836
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blood GlucoseDiabetes Mellitus, Type 1Hypoglycemic AgentsInsulin Infusion SystemsInsulin LisproAdolescentAdultAgedChildFemaleGlycated HemoglobinHumansHypoglycemiaMaleMiddle AgedPatient SatisfactionBlood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulin Lisproadultshybrid closed-loop systemspediatricsultrafast-acting insulin analogs

Identifiers

PMID38696672
PMCPMC12604941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.